| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Veterinary Pathology (YF, HN, KU, KD) and Veterinary Surgery (RN, NS), Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan
In canine mammary tumors, we examined the telomerase activity, proliferative activity by proliferative cell nuclear antigen (PCNA) immunohistochemistry, and percentage of apoptotic cells by the deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling (TUNEL) method. The relationship between these measures and histopathologic malignancy was also investigated. PCNA index was highest in malignant tumors (adenocarcinoma: 27.0%; malignant mixed tumor: 15.7%), followed by benign tumors (adenoma: 4.4%; benign mixed tumor: 5.3%), hyperplasia (2.1%), and normal mammary gland (0.9%). In adenoma and adenocarcinoma, papillary and solid types showing higher cellularity tended to have higher PCNA indices than did cystic and tubular types. Although the TUNEL index was <1% in all cases, the relationship between this measure and histopathologic diagnosis showed the same tendency as observed in PCNA immunostaining. Telomerase activity was detectable in all adenomas, benign mixed tumors, and adenocarcinomas examined. In contrast, all normal mammary glands, hyperplasias, and malignant mixed tumors were negative for telomerase. Relative telomerase activity (RTA) of adenocarcinoma (56.5) was significantly higher than that of adenoma (27.8) and benign mixed tumor (33.9), and a significant positive correlation (P < 0.001) was noted between RTA and PCNA index. No significant correlations were noted between either PCNA or TUNEL index and clinical features such as metastasis and tumor diameter. PCNA index and telomerase activity may be useful markers for judging malignancy of canine mammary tumors.
Key words: Dog; mammary gland tumor; PCNA; telomerase activity; TUNEL.
Request reprints from Kunio Doi or Hiroyuki Nakayama, Department of Veterinary Pathology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657 (Japan). E-mail: akunio{at}mail.ecc.u-tokyo.ac.jp or anakaya{at}mail.ecc.u-tokyo.ac.jp.
This article has been cited by other articles:
![]() |
L. N. Torres, J. M. Matera, C. H. Vasconcellos, J. L. Avanzo, F. J. Hernandez-Blazquez, and M. L. Z. Dagli Expression of Connexins 26 and 43 in Canine Hyperplastic and Neoplastic Mammary Glands Vet. Pathol., September 1, 2005; 42(5): 633 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Argyle and L. Nasir Telomerase: A Potential Diagnostic and Therapeutic Tool in Canine Oncology Vet. Pathol., January 1, 2003; 40(1): 1 - 7. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |